Imagine a device that can make heart cells beat in perfect rhythm using nothing but light—no metal wires, no electrodes, just soft, flexible materials interacting directly with living tissue. Researchers at the University of California, Irvine, have turned this vision into reality with the creation of a polymeric biohybrid cardiac device that can electrically and mechanically control heart tissue using light. Published in Cell Biomaterials, this innovation marks a major leap forward in how heart disease is studied, cardiac drugs are tested, and potentially how life-saving therapies are delivered in the future.
A New Approach to Cardiac Stimulation
Traditional methods of controlling heart cells in the lab rely on rigid metal electrodes. While effective at generating electrical signals, these electrodes come with significant drawbacks. Over time, they can damage delicate tissue, introduce contamination, or fail to mimic the natural environment of the beating heart. The UC Irvine team overcame these challenges by developing a light-driven, flexible biohybrid platform that communicates with heart cells in their own “language” of electrical and mechanical pulses.
The device works by layering optoelectronic polymer films directly onto living cardiac cells. These polymers have special properties that allow them to convert visible light into tiny electrical currents—called photocurrents. When pulsed with gentle green light, these currents trigger the heart cells to contract in sync, simulating a natural heartbeat. The resulting device is soft, flexible, and free from the mechanical and contamination issues associated with conventional electrodes.
“What we’ve built is essentially a light-powered interface that speaks in electrical and mechanical pulses, the same language as the heart, without any of the drawbacks of rigid electrodes,” said Herdeline “Digs” Ardoña, UC Irvine assistant professor of chemical and biomolecular engineering and co-author of the study.
How the Device Works
At the heart of the system is a multilayer polymer design. The topmost layer contains donor-acceptor junctions, capable of generating photocurrents when illuminated. A second composite layer interfaces directly with the biological environment, enhancing charge transport, stability in aqueous conditions, and compatibility with living cells.
“When submerged in cell culture medium and illuminated, the polymeric blend generates a charge-transfer state that drives ionic redistribution at the polymer-electrolyte interface,” explained lead author Yuyao Kuang, who recently completed a Ph.D. in chemical and biomolecular engineering at UC Irvine. “This creates a gentle, localized electrical stimulus for heart cells growing on the surface.”
Unlike optogenetics, which requires genetic modification to make cells light-sensitive, this approach works on native, unmodified cardiac tissue. This opens the door for more direct applications in laboratory research and, eventually, in patients.
Mimicking the Heart’s Natural Architecture
The team cultured neonatal rat ventricular myocytes, a common model for human heart cells, on the optoelectronic substrate. The cells were arranged in an anisotropic, micropatterned design that closely mirrors the organized fiber structure of natural heart muscle.
This layered structure was then formed into a muscular thin film with a cantilever geometry. This allowed researchers to visually observe and measure the bending movements of the film as the cardiac cells contracted in response to light pulses. This setup provides a unique way to measure both electrical pacing and mechanical contraction in real time.
Impact on Cardiac Research and Drug Testing
One of the most immediately exciting applications of this technology is in pharmaceutical research. Developing drugs that affect heart function is challenging because current laboratory models are limited. Rigid electrodes can damage cells or introduce measurement errors, while simpler models often fail to replicate the heart’s complex electromechanical environment.
The UC Irvine biohybrid platform allows researchers to observe the effects of drugs directly on living, light-paced cardiac tissue. They can monitor changes in contractile strength, mechanical strain, and structural remodeling of protein networks over time—all in one integrated experiment. This provides a much clearer picture of a drug’s true effects on heart function than traditional in vitro systems.
“By applying a candidate drug directly to the living tissue, we can see in real time how it affects the heart’s response to pacing and mechanical stress,” Ardoña said. “It’s a powerful tool for understanding heart disease and accelerating drug development.”
Towards Implantable Cardiac Therapies
Beyond laboratory research, the team envisions future versions of this technology as implantable cardiac patches. These conformable devices could wrap around diseased or damaged heart muscle and deliver precise, light-driven pacing therapy. Because the platform is soft and mechanically compliant, it is better suited to the constantly moving environment of the heart compared with traditional pacemaker electrodes.
The researchers are also exploring ways to use longer wavelengths of light, such as near-infrared, which can penetrate deeper through tissue. This advancement could make it possible to pace heart tissue non-invasively, a major step forward for future clinical applications.
Advantages Over Traditional Technologies
The light-driven biohybrid cardiac device has several notable advantages:
Non-invasive and gentle – No rigid metal components, reducing tissue damage and contamination risks.
Works on unmodified tissue – Unlike optogenetics, no genetic modification is needed.
Soft and flexible – Conforms to the natural movement of heart muscle.
Real-time functional feedback – Enables simultaneous measurement of electrical pacing and mechanical contraction.
Versatile applications – Useful in drug testing, disease modeling, and potentially therapeutic implantation.
These benefits address longstanding challenges in cardiac research and open doors to new avenues in both fundamental science and translational medicine.
Looking Ahead
While the technology is still in its experimental stages, the possibilities are enormous. In the near term, it could revolutionize drug screening and cardiac disease research, allowing scientists to study the heart in a more realistic and controlled way. In the longer term, light-powered cardiac patches could transform treatments for arrhythmias and other heart conditions, offering safer, more precise, and adaptive therapies.
As the UC Irvine team continues to refine this platform, the integration of optoelectronic polymers with living tissue may redefine how humans interface with their hearts, blending biology and technology in a way that was once purely science fiction.
“Ultimately, we hope to create devices that not only study the heart but help it heal,” Ardoña said. “Light is the key that lets us talk to the heart gently, safely, and effectively.”
Reference:
Yuyao Kuang et al., Optoelectronic biohybrid platform enables light-controlled cardiac structural and functional feedback, Cell Biomaterials (2026). DOI: 10.1016/j.celbio.2026.100416

Comments
Post a Comment